These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36378539)

  • 61. An update of antispike severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) monoclonal antibodies.
    Chatterjee S; Choudhury S; Das D
    Indian J Pharmacol; 2022; 54(1):51-57. PubMed ID: 35343208
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV.
    Jiang W; Wang J; Jiao S; Gu C; Xu W; Chen B; Wang R; Chen H; Xie Y; Wang A; Li G; Zeng D; Zhang J; Zhang M; Wang S; Wang M; Gui X
    MAbs; 2021; 13(1):1953683. PubMed ID: 34313527
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19 : A Cohort Study.
    Kip KE; McCreary EK; Collins K; Minnier TE; Snyder GM; Garrard W; McKibben JC; Yealy DM; Seymour CW; Huang DT; Bariola JR; Schmidhofer M; Wadas RJ; Angus DC; Kip PL; Marroquin OC
    Ann Intern Med; 2023 Apr; 176(4):496-504. PubMed ID: 37011399
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms.
    Peluso MJ; Deitchman AN; Torres L; Iyer NS; Munter SE; Nixon CC; Donatelli J; Thanh C; Takahashi S; Hakim J; Turcios K; Janson O; Hoh R; Tai V; Hernandez Y; Fehrman EA; Spinelli MA; Gandhi M; Trinh L; Wrin T; Petropoulos CJ; Aweeka FT; Rodriguez-Barraquer I; Kelly JD; Martin JN; Deeks SG; Greenhouse B; Rutishauser RL; Henrich TJ
    Cell Rep; 2021 Aug; 36(6):109518. PubMed ID: 34358460
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Monoclonal antibody treatment for COVID-19 in solid organ transplant recipients.
    Sarrell BA; Bloch K; El Chediak A; Kumm K; Tracy K; Forbes RC; Langone A; Thomas L; Schlendorf K; Trindade AJ; Perri R; Wright P; Concepcion BP
    Transpl Infect Dis; 2022 Feb; 24(1):e13759. PubMed ID: 34787345
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody.
    Phan T; Zitzmann C; Chew KW; Smith DM; Daar ES; Wohl DA; Eron JJ; Currier JS; Hughes MD; Choudhary MC; Deo R; Li JZ; Ribeiro RM; Ke R; Perelson AS;
    bioRxiv; 2023 Sep; ():. PubMed ID: 37745410
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A 1-year longitudinal study on COVID-19 convalescents reveals persistence of anti-SARS-CoV-2 humoral and cellular immunity.
    Li Y; Wang X; Shen XR; Geng R; Xie N; Han JF; Zhang QM; Shi ZL; Zhou P
    Emerg Microbes Infect; 2022 Dec; 11(1):902-913. PubMed ID: 35240947
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pre-existing immunity to SARS-CoV-2 associates with strong T cell responses induced by inactivated COVID-19 vaccines.
    Yi X; Wang Y; Li Q; Li X; Zhang P; Fu X; Gu S; Zhang D; Liu X; Lou H; Wu Y; Tang L; Hou J; Li Y
    J Med Virol; 2023 Mar; 95(3):e28642. PubMed ID: 36890630
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort.
    Vo HTM; Maestri A; Auerswald H; Sorn S; Lay S; Seng H; Sann S; Ya N; Pean P; Dussart P; Schwartz O; Ly S; Bruel T; Ly S; Duong V; Karlsson EA; Cantaert T
    Front Immunol; 2022; 13():817905. PubMed ID: 35185909
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Assessment of SARS-CoV-2 Immunity in Convalescent Children and Adolescents.
    Tsang HW; Chua GT; To KKW; Wong JSC; Tu W; Kwok JSY; Wong WHS; Wang X; Zhang Y; Rosa Duque JS; Chan GCF; Chu WK; Pang CP; Tam PKH; Lau YL; Wong ICK; Leung WH; Yuen KY; Kwan MYW; Ip P
    Front Immunol; 2021; 12():797919. PubMed ID: 34975908
    [TBL] [Abstract][Full Text] [Related]  

  • 71. SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patients.
    Gurevich M; Zilkha-Falb R; Sonis P; Magalashvili D; Menascu S; Flechter S; Dolev M; Mandel M; Achiron A
    Int J Infect Dis; 2022 Feb; 115():208-214. PubMed ID: 34896265
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Bamlanivimab Reduces ED Returns and Hospitalizations and May Reduce COVID-19 Burden on Low-resource Border Hospitals.
    Quenzer FC; Lafree AT; Grey L; Singh S; Smyers C; Balog B; Guedez HM; McIntyre K; Wulfovich S; Ramirez J; Saikhon T; Tomaszewski C
    West J Emerg Med; 2022 Mar; 23(3):302-311. PubMed ID: 35679495
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Therapeutic Monoclonal Antibody Bamlanivimab Does Not Enhance SARS-CoV-2 Infection by FcR-Mediated Mechanisms.
    Cross RW; Wiethoff CM; Brown-Augsburger P; Berens S; Blackbourne J; Liu L; Wu X; Tetreault J; Dodd C; Sina R; Witcher DR; Newcomb D; Frost D; Wilcox A; Borisevich V; Agans KN; Woolsey C; Prasad AN; Deer DJ; Geisbert JB; Dobias NS; Fenton KA; Strifler B; Ebert P; Higgs R; Beall A; Chanda S; Riva L; Yin X; Geisbert TW
    Pathogens; 2023 Nov; 12(12):. PubMed ID: 38133292
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab.
    Nytrova P; Stastna D; Tesar A; Menkyova I; Posova H; Koprivova H; Mikulova V; Hrdy J; Smela G; Horakova D; Rysankova I; Doleckova K; Tyblova M
    Front Immunol; 2023; 14():1149629. PubMed ID: 37398654
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Diffuse C4d staining of peritubular capillaries in renal allograft following bamlanivimab therapy.
    Klomjit N; El Ters M; Adam BA; Sampathkumar P; Razonable RR; Taler SJ; Taner T; Alexander MP
    Am J Transplant; 2022 Jan; 22(1):289-293. PubMed ID: 34358400
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Long COVID After Bamlanivimab Treatment.
    Evering TH; Moser CB; Jilg N; Yeh E; Sanusi B; Wohl DA; Daar ES; Li JZ; Klekotka P; Javan AC; Eron JJ; Currier JS; Hughes MD; Smith DM; Chew KW;
    J Infect Dis; 2023 Aug; 228(Suppl 2):S126-S135. PubMed ID: 37650236
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity.
    Lin J; Law R; Korosec CS; Zhou C; Koh WH; Ghaemi MS; Samaan P; Ooi HK; Matveev V; Yue F; Gingras AC; Estacio A; Buchholz M; Cheatley PL; Mohammadi A; Kaul R; Pavinski K; Mubareka S; McGeer AJ; Leis JA; Heffernan JM; Ostrowski M
    J Virol; 2022 Jul; 96(13):e0050922. PubMed ID: 35699447
    [TBL] [Abstract][Full Text] [Related]  

  • 78. One-Year Sustained Cellular and Humoral Immunities in Coronavirus Disease 2019 (COVID-19) Convalescents.
    Zhang J; Lin H; Ye B; Zhao M; Zhan J; Dong S; Guo Y; Zhao Y; Li M; Liu S; Zhang H; Xiao W; Guo Y; Yue C; Zhang D; Yang M; Zhang J; Quan C; Shi W; Liu X; Liu P; Jiang Y; Wu G; Gao GF; Liu WJ
    Clin Infect Dis; 2022 Aug; 75(1):e1072-e1081. PubMed ID: 34609506
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
    Havervall S; Ng H; Jernbom Falk A; Greilert-Norin N; Månberg A; Marking U; Laurén I; Gabrielsson L; Salomonsson AC; Aguilera K; Kihlgren M; Månsson M; Rosell A; Hellström C; Andersson E; Olofsson J; Skoglund L; Yousef J; Pin E; Lord M; Åberg M; Hedhammar M; Tegel H; Dönnes P; Phillipson M; Nilsson P; Klingström J; Mangsbo S; Hober S; Thålin C
    J Intern Med; 2022 Jan; 291(1):72-80. PubMed ID: 34459525
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A Propensity-Matched Cohort Assessing Impact of a Neutralizing Monoclonal Antibody in Mild-to-Moderate Coronavirus Disease 2019.
    Abbas M; Farhat N; Hammoud Z; Dickey C; Shuayto A; Chen NW; Hsaiky LM; Sims M; Sengstock D; Schramski J; Shamoon Z
    J Intensive Care Med; 2023 Jun; 38(6):511-518. PubMed ID: 36775970
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.